Article
SARS-CoV-2 variants and bebtelovimab: immune escape mechanisms revealed by computational studies.
Physical chemistry chemical physics : PCCP - 11 Dec 2024
Roy Rakesh Kumar, Sharma Madhur, Patra Niladri
Abstract excerpt
The receptor binding domain (RBD) of SARS-CoV-2 (coronavirus) targets and facilitates the binding with the human ACE2 receptor and is also a target for most monoclonal antibodies for the inhibition process. The emerging mutations in the RBD of SARS-CoV-2 are problematic, as their local and non-local effects can disrupt the binding mechanism of the antibody with the coronavirus's viral protein, thus compromising...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
